BlackRock Technology and Private Equity Term Trust
NYSE: BTX · FINANCIAL SERVICES · ASSET MANAGEMENT
Updated 2026-06-05
BlackRock Technology and Private Equity Term Trust (BTX) Insider transactions
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-10 | CHERINGTON, CHARLES | 10% Owner | Buy | 4,000,000 | — | — |
| 2026-02-10 | CHERINGTON, CHARLES | 10% Owner | Buy | 4,000,000 | $0.50 | $2.00M |
| 2025-06-21 | GURROLA, SANDRA M | Sr. VP of Finance | Buy | 30 | — | — |
| 2025-06-21 | GURROLA, SANDRA M | Sr. VP of Finance | Buy | 30 | — | — |
| 2025-06-09 | CHERINGTON, CHARLES | 10% Owner | Buy | 21,241,163 | $0.10 | $2.22M |
| 2025-04-02 | CHERINGTON, CHARLES | 10% Owner | Buy | 3,768,397 | $0.10 | $394174.33 |
| 2025-02-07 | WEXLER, WILLIAM A. | Director | Buy | 124,533 | — | — |
| 2025-02-07 | LUTHER, SANJEEV | Director, President & CEO | Buy | 1,123,350 | — | — |
| 2025-02-07 | GURROLA, SANDRA M | Sr. VP of Finance | Buy | 150,000 | — | — |
| 2025-02-07 | CICALA, PETER | Director | Buy | 51,485 | — | — |
| 2025-02-07 | BRISTOL, JAMES ARTHUR | Director | Buy | 72,074 | — | — |
| 2025-01-13 | RATNER, ELENA | Director | Buy | 140,078 | — | — |
| 2024-10-29 | CHERINGTON, CHARLES | 10% Owner | Sale | 3,125,976 | — | — |
| 2024-10-29 | CHERINGTON, CHARLES | 10% Owner | Sale | 2,475,524 | — | — |
| 2024-10-29 | CHERINGTON, CHARLES | 10% Owner | Sale | 523,512 | — | — |
| 2024-10-29 | CHERINGTON, CHARLES | 10% Owner | Buy | 5,420,823 | — | — |
| 2024-10-29 | CHERINGTON, CHARLES | 10% Owner | Buy | 4,768,783 | — | — |
| 2024-10-29 | CHERINGTON, CHARLES | 10% Owner | Buy | 2,819,546 | $0.50 | $1.41M |
| 2024-10-29 | CHERINGTON, CHARLES | 10% Owner | Buy | 1,562,988 | — | — |
| 2024-10-29 | CHERINGTON, CHARLES | 10% Owner | Buy | 1,237,762 | — | — |
| 2024-10-29 | CHERINGTON, CHARLES | 10% Owner | Buy | 261,756 | — | — |
| 2024-10-29 | CHERINGTON, CHARLES | 10% Owner | Sale | — | — | — |
| 2024-10-29 | CHERINGTON, CHARLES | 10% Owner | Sale | — | — | — |
| 2024-10-29 | CHERINGTON, CHARLES | 10% Owner | Sale | — | — | — |
| 2024-09-24 | CHERINGTON, CHARLES | 10% Owner | Sale | 3,125,976 | — | — |
| 2024-09-24 | CHERINGTON, CHARLES | 10% Owner | Sale | 2,475,524 | — | — |
| 2024-09-24 | CHERINGTON, CHARLES | 10% Owner | Sale | 523,512 | — | — |
| 2024-09-24 | CHERINGTON, CHARLES | 10% Owner | Buy | 5,420,823 | — | — |
| 2024-09-24 | CHERINGTON, CHARLES | 10% Owner | Buy | 4,768,783 | — | — |
| 2024-09-24 | CHERINGTON, CHARLES | 10% Owner | Buy | 1,562,988 | — | — |
| 2024-09-24 | CHERINGTON, CHARLES | 10% Owner | Buy | 1,237,762 | — | — |
| 2024-09-24 | CHERINGTON, CHARLES | 10% Owner | Buy | 261,756 | — | — |
| 2024-09-24 | CHERINGTON, CHARLES | 10% Owner | Sale | — | — | — |
| 2024-09-24 | CHERINGTON, CHARLES | 10% Owner | Buy | — | $1,368,626.00 | — |
| 2024-09-24 | CHERINGTON, CHARLES | 10% Owner | Sale | — | — | — |
| 2024-09-23 | CHERINGTON, CHARLES | 10% Owner | Buy | 83,916 | — | — |
| 2024-09-23 | CHERINGTON, CHARLES | 10% Owner | Buy | — | — | — |
| 2024-06-21 | GURROLA, SANDRA M | Sr. VP of Finance | Sale | 437 | — | — |
| 2024-06-21 | GURROLA, SANDRA M | Sr. VP of Finance | Buy | 437 | — | — |
| 2024-06-21 | GURROLA, SANDRA M | Sr. VP of Finance | Sale | 180 | $1.94 | $349.20 |
| 2024-04-26 | GURROLA, SANDRA M | Sr. VP of Finance | Buy | 80,000 | — | — |
| 2024-04-26 | CICALA, PETER | Director | Buy | 88,946 | — | — |
| 2024-04-26 | BRISTOL, JAMES ARTHUR | Director | Buy | 124,525 | — | — |
| 2024-01-01 | LUTHER, SANJEEV | Director, President and CEO | Buy | 1,685,218 | — | — |
| 2024-01-01 | CLARKE, DOROTHY J | Director, General Counsel | Buy | 168,521 | — | — |
| 2023-12-15 | FREEBIRD, PARTNERS LP | 10% Owner | Buy | 520,996 | $1.92 | $999999.72 |
| 2023-12-15 | FREEBIRD, PARTNERS LP | 10% Owner | Buy | 1,041,992 | — | — |
| 2023-12-14 | FREEBIRD, PARTNERS LP | 10% Owner | Buy | 524,474 | — | — |
| 2023-12-14 | FREEBIRD, PARTNERS LP | 10% Owner | Buy | 424,928 | — | — |
| 2023-12-14 | CHERINGTON, CHARLES | 10% Owner | Buy | 3,125,976 | $0.13 | $390747.00 |
| 2023-12-14 | CHERINGTON, CHARLES | 10% Owner | Buy | 2,307,692 | — | — |
| 2023-12-14 | CHERINGTON, CHARLES | 10% Owner | Sale | 523,512 | — | — |
| 2023-12-14 | CHERINGTON, CHARLES | 10% Owner | Buy | — | $3,000,000.00 | — |
| 2023-07-14 | FREEBIRD, PARTNERS LP | 10% Owner | Buy | 262,237 | $2.86 | $749997.82 |
| 2023-07-14 | FREEBIRD, PARTNERS LP | 10% Owner | Buy | 524,474 | — | — |
| 2023-07-13 | WAGNER, RICHARD W | Director | Buy | 83,916 | $0.13 | $10489.50 |
| 2023-07-13 | WAGNER, RICHARD W | Director | Buy | — | $120,000.00 | — |
| 2023-07-13 | CHERINGTON, CHARLES | 10% Owner | Buy | 2,307,692 | $0.13 | $288461.50 |
| 2023-07-13 | CHERINGTON, CHARLES | 10% Owner | Buy | — | $3,300,000.00 | — |
| 2023-07-13 | BINDER, BRANT | Director | Buy | 83,916 | $0.13 | $10489.50 |
| 2023-07-13 | BINDER, BRANT | Director | Buy | — | $120,000.00 | — |
| 2023-06-21 | GURROLA, SANDRA M | Vice President of Finance | Sale | 438 | — | — |
| 2023-06-21 | GURROLA, SANDRA M | Vice President of Finance | Buy | 438 | — | — |
| 2023-06-21 | GURROLA, SANDRA M | Vice President of Finance | Sale | 179 | $2.48 | $443.92 |
| 2023-01-12 | ANGEL, MATTHEW | Director, President and CEO | Buy | 132,003 | — | — |
| 2022-12-02 | SINGER, NICHOLAS JASON | Director | Buy | 424,928 | $0.13 | $53116.00 |
| 2022-12-02 | SINGER, NICHOLAS JASON | Director | Buy | 141,644 | $0.13 | $17705.50 |
| 2022-12-02 | SINGER, NICHOLAS JASON | Director | Buy | 212,464 | $3.28 | $696881.92 |
| 2022-12-02 | SINGER, NICHOLAS JASON | Director | Buy | 70,822 | $3.28 | $232296.16 |
| 2022-12-02 | HALPERN, JOHN D | 10% Owner | Buy | 671,840 | $0.13 | $83980.00 |
| 2022-12-02 | HALPERN, JOHN D | 10% Owner | Buy | 335,920 | $3.28 | $1.10M |
| 2022-12-02 | CHERINGTON, CHARLES | Director, 10% Owner | Buy | 523,512 | $0.13 | $65439.00 |
| 2022-12-02 | CHERINGTON, CHARLES | Director, 10% Owner | Buy | 261,756 | $3.28 | $858559.68 |
| 2022-09-20 | SIDHU, ROGER | Chief Medical Officer | Sale | 20,163 | — | — |
| 2022-09-20 | SIDHU, ROGER | Chief Medical Officer | Buy | 20,163 | — | — |
| 2022-08-01 | WEXLER, WILLIAM A. | Director | Buy | 165,800 | — | — |
| 2022-08-01 | WEXLER, WILLIAM A. | Director | Buy | 152,100 | — | — |
| 2022-08-01 | SINGER, NICHOLAS JASON | Director | Buy | 165,800 | — | — |
| 2022-08-01 | SINGER, NICHOLAS JASON | Director | Buy | 146,100 | — | — |
| 2022-08-01 | FIORE, GREGORY | Director | Buy | 165,800 | — | — |
| 2022-08-01 | FIORE, GREGORY | Director | Buy | 95,100 | — | — |
| 2022-08-01 | CHERINGTON, CHARLES | Director | Buy | 215,100 | — | — |
| 2022-08-01 | CHERINGTON, CHARLES | Director | Buy | 165,800 | — | — |
| 2022-08-01 | ANGEL, MATTHEW | Director, Interim President and CEO | Buy | 2,487,003 | — | — |
| 2022-06-28 | DAMOUR, KEVIN | Chief Scientific Officer | Sale | 17,573 | — | — |
| 2022-06-28 | DAMOUR, KEVIN | Chief Scientific Officer | Buy | 17,573 | — | — |
| 2022-06-28 | DAMOUR, KEVIN | Chief Scientific Officer | Sale | 6,077 | $0.55 | $3363.01 |
| 2022-06-21 | GURROLA, SANDRA M | Vice President of Finance | Sale | 8,750 | — | — |
| 2022-06-21 | GURROLA, SANDRA M | Vice President of Finance | Buy | 8,750 | — | — |
| 2022-06-21 | GURROLA, SANDRA M | Vice President of Finance | Sale | 3,586 | $0.48 | $1708.73 |
| 2022-06-03 | JACKSON, ANDREW C. | Chief Financial Officer | Buy | 664,800 | — | — |
| 2022-03-11 | SIDHU, ROGER | Chief Medical Officer | Buy | 142,100 | — | — |
| 2022-03-11 | SIAL, JAY | Chief Administration Officer | Buy | 117,200 | — | — |
| 2022-03-11 | GURROLA, SANDRA M | Vice President of Finance | Buy | 114,500 | — | — |
| 2022-03-11 | FEDEROFF, HOWARD J. | Director, CEO & President | Buy | 413,700 | — | — |
| 2022-03-11 | DAMOUR, KEVIN | Chief Scientific Officer | Buy | 138,400 | — | — |
| 2022-01-14 | REDMAN, HEATHER B | Director | Buy | 67,000 | — | — |
| 2022-01-14 | ENRIGHT, ERIN S. | Director | Buy | 67,000 | — | — |
| 2021-12-08 | MOHR, ERICH | Director | Buy | 67,000 | — | — |
| 2021-12-08 | LANGER, DENNIS | Director | Buy | 67,000 | — | — |
Frequently asked questions
Are BTX insiders buying or selling?
Over the transactions on record, BTX insiders have been net buyers, with about $5864.86 in stock sold across 21 sales, against 23 open-market purchases.
Does insider selling at BTX mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which BTX insiders are selling the most?
Recent selling is concentrated in a few names. DAMOUR, KEVIN accounts for the largest share on record, with about $3363.01 sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.